Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
kidney transplant patients
.
Show all posts
Showing posts with label
kidney transplant patients
.
Show all posts
Friday, October 2, 2015
Envarsus XR granted FDA orphan drug designation for prophylaxis of organ rejection in kidney transplant patients
›
Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that Envarsus ® XR was granted Orphan Drug status by the U.S. F...
›
Home
View web version
